Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative tranexamic acid in gastric bypass to reduce hemorrhage
NL-OMON58931Phase 3Recruiting
- Sponsor
- Franciscus Gasthuis & Vlietland
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of tranexamic acid in class III obesity (2 arms), sponsored by Franciscus Gasthuis & Vlietland. Primary endpoint: Postoperative intervention due to haemorrhage. Started Apr 2023; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
class III obesity
Beyond the preview
Go deeper on NL-OMON58931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON58931.